repeated episodes of retching and vomiting were also less frequent in the scopolamine group compared with the placebo group ( 23 % vs. 41 % ; p = 0.0213 ) as was the need for additional antiemetic therapy ( 13 % vs. 32 % ; p = 0.0013 ) .
C0042963
vomiting
C0036442
scopolamine